← Open Payments lookup

EBERHARD MAENDEL: Open Payments

NPI 1639171283 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,832 in 181 payments from 22 companies in 2025. Trend: 2023 $2,520 · 2024 $4,524 · 2025 $3,832

Food & beverage: $3,409Education: $423
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.17$483
Janssen Biotech, Inc.15$410
PFIZER INC.21$387
ABBVIE INC.19$383
SUN PHARMACEUTICAL INDUSTRIES INC.14$378
Galderma Laboratories, L.P.16$348
UCB, Inc.14$235
Novartis Pharmaceuticals Corporation7$165
Organon LLC10$164
Amgen Inc.8$157

Products named: DUPIXENT, TREMFYA, CIBINQO, NEMLUVIO, Bimzelx, SKYRIZI, COSENTYX, RINVOQ.

Industry payments across NV — which companies pay providers there.